Cirrhosis echocardiography or ultrasound: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 22: Line 22:
*[[Splenomegaly]] and collaterals from [[portal hypertension]] may be noted.
*[[Splenomegaly]] and collaterals from [[portal hypertension]] may be noted.


A new type of device, the FibroScan (transient elastography), uses elastic waves to determine liver stiffness which theoretically can be converted into a liver score based on the METAVIR scale.  The FibroScan produces an ultrasound image of the liver (from 20-80mm) along with a pressure reading (in kPa.)  The test is much faster than a biopsy (usually last 2.5-5 minutes) and is completely painless.  It shows reasonable corellation with the severity of cirrhosis.<ref>{{cite journal |author=Foucher J, Chanteloup E, Vergniol J, ''et al'' |title=Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study |journal=Gut |volume=55|issue=3 |pages=403-8 |year=2006 |pmid=16020491 |doi=10.1136/gut.2005.069153}}</ref>
A new type of device, the '''FibroScan (transient elastography)''', uses elastic waves to determine liver stiffness which theoretically can be converted into a liver score based on the METAVIR scale.  The FibroScan produces an ultrasound image of the liver (from 20-80mm) along with a pressure reading (in kPa.)  The test is much faster than a biopsy (usually last 2.5-5 minutes) and is completely painless.  It shows reasonable corellation with the severity of cirrhosis.<ref>{{cite journal |author=Foucher J, Chanteloup E, Vergniol J, ''et al'' |title=Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study |journal=Gut |volume=55|issue=3 |pages=403-8 |year=2006 |pmid=16020491 |doi=10.1136/gut.2005.069153}}</ref>


==References==
==References==

Revision as of 16:48, 6 September 2012

Cirrhosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cirrhosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Cirrhosis echocardiography or ultrasound On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cirrhosis echocardiography or ultrasound

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cirrhosis echocardiography or ultrasound

CDC on Cirrhosis echocardiography or ultrasound

Cirrhosis echocardiography or ultrasound in the news

Blogs on Cirrhosis echocardiography or ultrasound

Directions to Hospitals Treating Cirrhosis

Risk calculators and risk factors for Cirrhosis echocardiography or ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Overview

On ultrasonography, changes in liver contours and nodularity may be evident. The echo texture may appear coarsened along with increase in echogenecity from focal fatty changes and irregular appearing areas. It can also be used to screen for hepatocellular carcinoma, portal hypertension and Budd-Chiari syndrome.

Echocardiography

Echocardiogram may be helpful in measuring the ejection fraction, and ischemic and hypokinetic areas of the ventricles in establishing diagnosis of congestive cardiac failure as a cause of liver cirrhosis.

Ultrasound

Following changes may be noted:

  • Changes in liver contour
  • Nodularity
  • Increase in echogenecity from focal fatty infiltration
  • Vascular changes:
    • Flow across both portal and systemic circulation increases
    • Resistive Index increases in end stage liver disease
    • Vessels appear elongated and tortuous, called "corkscrewing" of the vessels
    • Doppler ultrasound may show spontaneous shunts
  • Splenomegaly and collaterals from portal hypertension may be noted.

A new type of device, the FibroScan (transient elastography), uses elastic waves to determine liver stiffness which theoretically can be converted into a liver score based on the METAVIR scale. The FibroScan produces an ultrasound image of the liver (from 20-80mm) along with a pressure reading (in kPa.) The test is much faster than a biopsy (usually last 2.5-5 minutes) and is completely painless. It shows reasonable corellation with the severity of cirrhosis.[1]

References

  1. Foucher J, Chanteloup E, Vergniol J; et al. (2006). "Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study". Gut. 55 (3): 403–8. doi:10.1136/gut.2005.069153. PMID 16020491.

Template:WH

Template:WS